Beta Drugs Limited — Board Meeting, 05-02-2025: Outcome of Board Meeting

The Board of Directors of Beta Drugs Limited has announced a board meeting where several key decisions were made. The authorized share capital of the company will be increased from ₹10.50 crore to ₹11 crore, subject to shareholder approval. A bonus share issue of 1:20 was approved, allowing shareholders to receive one bonus share for every twenty existing shares held. Additionally, Mrs. Monika Jain and Mr. Lalit Kumar Watts have been appointed as independent directors. The company also noted the resignation of Mrs. Seema Chopra as Whole-Time Director. Plans for migration of the company's shares from the Emerge platform to the main board of NSE and BSE were confirmed.